Extra-Fine Single-Inhaler Triple Therapy useful for Severe Asthma with small airways dysfunction, may delay need for biological therapies: Study Medha Baranwal9 March 2025 9:00 PM ISTChina: Severe asthma remains a major healthcare challenge, contributing to increased morbidity, reduced quality of life, and higher healthcare costs. ...
Tobacco Exposure Doesn't Affect Biologic Treatment for Severe Asthma, Study Shows Medha Baranwal14 Jan 2025 8:45 PM ISTDenmark: A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that ex-smokers with severe asthma respond to...
Depemokimab reduces exacerbations in patients with severe asthma with eosinophilic phenotype, reveals study Dr.Niharika Harsha B27 Dec 2024 9:15 PM ISTA recent novel study published in the New England Journal of Medicine found that Depemokimab can reduce asthma exacerbations in patients with the...
Long-Term Biologic Treatment tied to Clinical Remission in Nearly Half of Severe Asthma Patients: Study Reveals Medha Baranwal14 Nov 2024 8:00 PM ISTUSA: Recent findings published in The Journal of Allergy and Clinical Immunology highlight the potential for long-term biologic therapy to lead to...
Twice-Yearly Depemokimab Effectively Lowers Exacerbation Rates in Severe Eosinophilic Asthma: Study Reveals Medha Baranwal13 Oct 2024 8:30 PM ISTUSA: A recent study published in the New England Journal of Medicine highlights the effectiveness of Depemokimab, an innovative monoclonal antibody,...
CDSCO Panel approves AstraZeneca Pharma's Benralizumab solution for Injection in auto-injector Dr. Divya Colin1 Jun 2024 6:00 PM ISTNew Delhi: Granting the local phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Tezepelumab Effectively Reduces Asthma Exacerbations in Patients Across BMI Ranges Dr Riya Dave16 Oct 2023 10:15 AM ISTA post hoc analysis was conducted on the phase 3 NAVIGATOR study and the DESTINATION extension study. The analysis revealed that tezepelumab, a human...
Digital tools improve treatment adherence and among severe asthmatics: The Lancet Aditi27 April 2023 10:30 AM ISTIreland: According to a study published in Respiratory Medicine, the Lancet, Evidence-based care using digital data improves treatment adherence among...
CC16 predicts respiratory dysfunction and eosinophilic inflammation in severe asthma Medha Baranwal2 Jan 2023 8:00 PM ISTJapan: CC16 (Club cell 16-kDa secretory protein) may help predict rapid FEV1 decline and enhanced eosinophilic inflammation in patients with severe...
Mepolizumab demonstrates high clinical efficacy in both allergic and non-allergic Asthma Dr.Niharika Harsha B1 Dec 2022 10:30 AM ISTA new study revealed that mepolizumab is clinically very effective for the treatment of severe allergic and non-allergic phenotypes of asthma. The...
Excessive use of short-acting beta 2 agonists tied with extra extreme bronchial asthma Dr. Shravani Dali30 April 2022 9:00 AM ISTHigh use of short-acting beta 2 agonists is tied with more severe asthma, according to a recent study published in the Journal of Allergy Clinical...
Recommendations for management of severe asthma: Brazilian Thoracic Association Medha Baranwal18 Feb 2022 9:00 AM ISTBrazil: A recent study in the Brazilian Journal of Pulmonology reports 2021 Brazilian Thoracic Association recommendations for the management of...
